Affiliation:
1. School of Cellular and Molecular Medicine University of Bristol Bristol BS8 1TD UK
2. School of Biochemistry University of Bristol Bristol BS8 1TD UK
3. Research School of Chemistry Australian National University Canberra ACT 2601 Australia
4. Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science Australian National University Canberra ACT 2601 Australia
5. John Curtin School of Medical Research Australian National University Canberra ACT 2601 Australia
Abstract
AbstractMost organophosphates (OPs) are hydrophobic, and after exposure, can sequester into lipophilic regions within the body, such as adipose tissue, resulting in long term chronic effects. Consequently, there is an urgent need for therapeutic agents that can decontaminate OPs in these hydrophobic regions. Accordingly, an enzyme–polymer surfactant nanocomplex is designed and tested comprising chemically supercharged phosphotriesterase (Agrobacterium radiobacter; arPTE) electrostatically conjugated to amphiphilic polymer surfactant chains ([cat.arPTE][S−]). Experimentally‐derived structural data are combined with molecular dynamics (MD) simulations to provide atomic level detail on conformational ensembles of the nanocomplex using dielectric constants relevant to aqueous and lipidic microenvironments. These show the formation of a compact admicelle pseudophase surfactant corona under aqueous conditions, which reconfigures to yield an extended conformation at a low dielectric constant, providing insight into the mechanism underpinning cell membrane binding. Significantly, it demonstrated that [cat.arPTE][S−] spontaneously binds to human mesenchymal stem cell membranes (hMSCs), resulting in on‐cell OP hydrolysis. Moreover, the nanoconstruct can endocytose and partition into the intracellular fatty vacuoles of adipocytes and hydrolyze sequestered OP.
Funder
UK Research and Innovation
Engineering and Physical Sciences Research Council